IceCure Medical (ICCM) Invested Capital (2020 - 2025)

IceCure Medical (ICCM) has 6 years of Invested Capital data on file, last reported at $9.1 million in Q4 2025.

• Quarterly Invested Capital rose 31.15% year-over-year to $9.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.1 million (up 31.15% YoY) and the FY2025 annual result came in at $9.1 million, up 31.15% from the prior year.
• Invested Capital climbed to $9.1 million in Q4 2025 per ICCM's latest filing, from $6.9 million in the prior quarter.
• Across five years, Invested Capital topped out at $27.0 million in Q4 2021 and bottomed at $6.9 million in Q4 2024.
• The 5-year median for Invested Capital is $12.2 million (2023), against an average of $16.1 million.
• The widest annual swing landed in 2021, when Invested Capital surged 377.3%; it then slumped 52.16% in 2023.
• Tracing ICCM's Invested Capital over 5 years: stood at $27.0 million in 2021, then fell by 5.7% to $25.4 million in 2022, then slumped by 52.16% to $12.2 million in 2023, then tumbled by 43.26% to $6.9 million in 2024, then surged by 31.15% to $9.1 million in 2025.
• Per Business Quant, the three latest ICCM Invested Capital figures stand at $9.1 million (Q4 2025), $6.9 million (Q4 2024), and $12.2 million (Q4 2023).

Peer Comparison